257 related articles for article (PubMed ID: 36597055)
21. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.
Wang P; Wang Z; Liu Y; Xie J; Ren Y
Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of inflammation-based indexes in patients with stage III/IV colorectal cancer after adjuvant chemoradiotherapy.
Yang J; Guo X; Wu T; Niu K; Ma X
Medicine (Baltimore); 2019 Feb; 98(6):e14420. PubMed ID: 30732196
[TBL] [Abstract][Full Text] [Related]
23. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W
BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843
[TBL] [Abstract][Full Text] [Related]
24. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of serum inflammation indexes in different Lauren classification of gastric cancer.
Yin X; Fang T; Wang Y; Wang Y; Zhang D; Li C; Xue Y
Cancer Med; 2021 Feb; 10(3):1103-1119. PubMed ID: 33410261
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Local and Advanced Gastric Cancer Patients.
Aldemir MN; Turkeli M; Simsek M; Yildirim N; Bilen Y; Yetimoglu H; Bilici M; Tekin SB
Asian Pac J Cancer Prev; 2015; 16(14):5933-7. PubMed ID: 26320475
[TBL] [Abstract][Full Text] [Related]
27. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study.
Zhang LX; Wei ZJ; Xu AM; Zang JH
Int J Surg; 2018 Aug; 56():320-327. PubMed ID: 29969732
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
[TBL] [Abstract][Full Text] [Related]
29. Combining serum inflammation indexes at baseline and post treatment could predict pathological efficacy to anti‑PD‑1 combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma.
Zhang X; Gari A; Li M; Chen J; Qu C; Zhang L; Chen J
J Transl Med; 2022 Feb; 20(1):61. PubMed ID: 35109887
[TBL] [Abstract][Full Text] [Related]
30. Trajectories of neutrophil-to-lymphocyte ratios during neoadjuvant chemotherapy correlate with short- and long-term outcomes in gastric cancer: a group-based trajectory analysis.
Zheng HL; Wang FH; Zhang LK; Li P; Zheng CH; Chen QY; Huang CM; Xie JW
BMC Cancer; 2024 Feb; 24(1):226. PubMed ID: 38365617
[TBL] [Abstract][Full Text] [Related]
31. Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB.
Liu P; Jiang Y; Zheng X; Pan B; Xiang H; Zheng M
Pathol Oncol Res; 2022; 28():1610294. PubMed ID: 35570842
[No Abstract] [Full Text] [Related]
32. Pretreatment platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a predictor of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: single center experience from Turkey.
Acikgoz O; Yildiz A; Bilici A; Olmez OF; Basim P; Cakir A
Anticancer Drugs; 2022 Nov; 33(10):1150-1155. PubMed ID: 36206103
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.
Jia W; Yuan L; Ni H; Xu B; Zhao P
Technol Cancer Res Treat; 2021; 20():15330338211034291. PubMed ID: 34308689
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis.
Qi X; Chen J; Wei S; Ni J; Song L; Jin C; Yang L; Zhang X
BMJ Open; 2023 Nov; 13(11):e074874. PubMed ID: 37996220
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
[TBL] [Abstract][Full Text] [Related]
36. Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study.
Ding P; Guo H; Sun C; Yang P; Kim NH; Tian Y; Liu Y; Liu P; Li Y; Zhao Q
BMC Gastroenterol; 2022 Mar; 22(1):121. PubMed ID: 35287591
[TBL] [Abstract][Full Text] [Related]
37. The correlation between systemic inflammatory markers and efficiency for advanced gastric cancer patients treated with ICIs combined with chemotherapy.
Dong Q; Zhao F; Li Y; Song F; Li E; Gao L; Xin Y; Shen G; Ren D; Wang M; Zhao Y; Liu Z; Xie Q; Liu Z; Li Z; Zhao J
Immunology; 2024 May; 172(1):77-90. PubMed ID: 38269606
[TBL] [Abstract][Full Text] [Related]
38. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
[TBL] [Abstract][Full Text] [Related]
39. Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.
Huang Z; Liu Y; Yang C; Li X; Pan C; Rao J; Li N; Liao W; Lin L
BMC Cancer; 2018 May; 18(1):515. PubMed ID: 29720123
[TBL] [Abstract][Full Text] [Related]
40. Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer.
Hou Y; Li X; Yang Y; Shi H; Wang S; Gao M
Front Immunol; 2023; 14():1274431. PubMed ID: 38022654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
